The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GSK GLAXOSMITHKLINE PLC ORD 25P




 Page 8 of 10

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Time/Date Code Headline Source Impact
11:32 10-Nov-2014 GSK Director/PDMR Shareholding RNS +1.77% Up
13:51 07-Nov-2014 GSK Director/PDMR Shareholding RNS +1.13% Up
11:19 07-Nov-2014 GSK Director/PDMR Shareholding RNS +1.13% Up
11:22 05-Nov-2014 GSK Regulatory submissions for mepolizumab RNS +1.22% Up
11:22 03-Nov-2014 GSK Total Voting Rights RNS +1.39% Up
15:53 29-Oct-2014 GSK Director/PDMR Shareholding RNS +0.77% Up
18:30 27-Oct-2014 GSK Publication of Supplementary Prospectus RNS +1.66% Up
16:15 27-Oct-2014 GSK Director/PDMR Shareholding RNS +1.66% Up
14:17 27-Oct-2014 GSK Director/PDMR Shareholding RNS +1.66% Up
17:46 24-Oct-2014 GSK Director/PDMR Shareholding RNS +2.53% Up
17:26 23-Oct-2014 GSK Director/PDMR Shareholding RNS +4.08% Up
12:12 22-Oct-2014 GSK Re Directorate RNS +4.48% Up
12:00 22-Oct-2014 GSK 3rd Quarter Results RNS +4.48% Up
16:12 20-Oct-2014 GSK Director/PDMR Shareholding RNS +2.00% Up
16:08 20-Oct-2014 GSK Director/PDMR Shareholding RNS +2.00% Up
16:04 20-Oct-2014 GSK Director/PDMR Shareholding RNS +2.00% Up
15:59 20-Oct-2014 GSK Director/PDMR Shareholding RNS +2.00% Up
17:40 14-Oct-2014 GSK Director/PDMR Shareholding RNS -3.27% Down
17:34 14-Oct-2014 GSK Director/PDMR Shareholding RNS -3.27% Down
17:15 14-Oct-2014 GSK Director/PDMR Shareholding RNS -3.27% Down

 Page 8 of 10

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 64,588.22
Listing/Admission to trading 22 May 1972
Trading service -
Market -
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
29-Jul-15
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



GLAXOSMITHKLINE share - news analysis